Sardu C, Modugno P, Castellano G, Scisciola L, Barbieri M, Petrella L, Fanelli M, Macchia G, Caradonna E, Massetti M et al
However, given the small number of available studies and the limited reproducibility of fMRI cue-reactivity paradigms with few trials and participants, such interpretations should be viewed as provisional
Talakoub notes that beyond suppressing appetite, the medication is helping patients change their underlying behavior: One of the things that I found the semaglutide does is it teaches people what they can and cannot eat
pharmacy licensure and regulatory compliance
doi:10.1016/j.jbbm.2005.08.001 57
Key stat: 63% of millennials and 61% of Gen Zers feel more connected to health brands since starting GLP-1s, per a January Dentsu report